GATA1 Promotes Gemcitabine Resistance in Pancreatic Cancer through Antiapoptotic Pathway

Gemcitabine-based chemotherapy is the first-line treatment for pancreatic cancer. However, chemoresistance is a major obstacle to drug efficacy, leading to poor prognosis. Little progress has been achieved although multiple mechanisms are investigated. Therefore, effective strategies are urgently ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Zhenyu, Zhang, Yanan, Liu, Jie, Guan, Chengjian, Gu, Xinjin, Yang, Zelong, Ye, Qinong, Ding, Lihua, Liu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481023/
https://www.ncbi.nlm.nih.gov/pubmed/31093285
http://dx.doi.org/10.1155/2019/9474273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481023/
https://www.ncbi.nlm.nih.gov/pubmed/31093285
http://dx.doi.org/10.1155/2019/9474273

Ejemplares similares